Overview: Homogentisic Acid TestIntroduction: The Homogentisic Acid Test tests for homogentisic acid to diagnose alkaptonuria, causing joint pain or dark urine, helping guide management of this rare condition. Affecting 1 in 250,000 people, alkaptonuria poses diagnostic challenges due to late onset. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses GC-MS for high accuracy, supporting biochemistry screening. This test is vital for diagnosis, treatment planning, and improving outcomes in metabolism.
Other Names: Homogentisic Acid Test, Alkaptonuria Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Homogentisic acid testing began in the 1950s with research by La Du, who linked it to alkaptonuria. GC-MS advancements in the 1990s by Agilent improved detection, surpassing earlier colorimetric methods.
Purpose: Measures homogentisic acid levels to diagnose alkaptonuria, guides dietary or supportive therapy, and evaluates patients with joint pain, aiming to manage symptoms.
Test Parameters: Homogentisic acid levels
Pretest Condition: No special preparation required. Collect urine. Report history of joint or urinary issues.
Specimen: Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document joint pain or dark urine. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., arthritis), and sample collection risks.
Procedural Considerations: Uses GC-MS to measure homogentisic acid, requiring labs with gas chromatographs. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may not affect results but require correlation.
Clinical Significance: Elevated homogentisic acid confirms alkaptonuria, guiding therapy. Early management might prevent complications, while untreated cases lead to arthritis. Normal levels may require genetic tests.
Specialist Consultation: Consult a metabolic specialist for interpretation.
Additional Supporting Tests: Urine ochronosis, joint imaging, or genetic panel to confirm diagnosis.
Test Limitations: Specific to homogentisic acid; correlation with symptoms needed. False negatives possible with low levels.
References: ACMG Guidelines, 2023; Journal of Clinical Investigation, La Du BN, 2022.
